Abstract
Down syndrome (DS) is caused by a unique metabolic imbalance induced by overexpression of genes on chromosome 21. The enzyme superoxide dismutase (SOD) is responsible for the regulation of reactive oxygen species (ROS) homeostasis. Increased levels or activity of SOD may contribute to neuronal death and disease progression in DS and precede the signature manifestations of the disease by decades. Individuals with DS have a higher prevalence and severity of periodontal disease, which cannot be explained by poor oral hygiene alone and is related to changes in the immune response. Using electron spin resonance (ESR) and spin trapping, we have obtained clear and direct evidence that ROS are generated in the media of cultured gingival cells from DS patients.
A number of findings in the past decade have prompted interest in the diagnostic use of saliva biomarkers. The salivary levels of oxidative stress biomarkers such as 8-hydroxy-2′-deoxyguanosine (8-OHdG) have been shown to be significantly higher in DS patients than in control subjects, suggesting that high oxidative stress may lead to some of the clinical features of DS, especially rapidly progressive periodontal disease associated with premature aging. In the future, analysis of biomarkers such as 8-OHdG in saliva samples could be useful for the assessment and management of periodontal disease with oxidative stress in DS patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Perluigi M, Butterfield DA (2012) Oxidative stress and Down syndrome: a route toward Alzheimer-like dementia. Curr Gerontol Geriatr Res 2012:724904
Schuchmann S, Heinemann U (2000) Increased mitochondrial superoxide generation in neurons from trisomy 16 mice: a model of Down’s syndrome. Free Radic Biol Med 28:235–250
Busciglio J, Yankner BA (1995) Apoptosis and increased generation of reactive oxygen species in Down’s syndrome neurons in vitro. Nature 378:776–779
Komatsu T, Lee MC, Miyagi A et al (2006) Reactive oxygen species generation in gingival fibroblasts of Down syndrome patients detected by electron spin resonance spectroscopy. Redox Rep 11:71–77
Hayakawa M, Hattori K, Sugiyama S et al (1992) Age-associated oxygen damage and mutations in mitochondrial DNA in human hearts. Biochem Biophys Res Commun 189:979–985
Campos C, Guzman R, Lopez-Fernandez E et al (2011) Evaluation of urinary biomarkers of oxidative/nitrosative stress in adolescents and adults with Down syndrome. Biochim Biophys Acta 1812:760–768
Sawamoto Y, Sugano N, Tanaka H et al (2005) Detection of periodontopathic bacteria and an oxidative stress marker in saliva from periodontal disease patients. Oral Microbiol Immunol 20:216–220
Yasuda M, Ide H, Furuya K et al (2008) Salivary 8-OHdG: a useful biomarker for predicting severe ED and hypogonadism. J Sex Med 5:1482–1491
Komatsu T, Duckyoung Y, Ito A et al (2013) Increased oxidative stress biomarkers in the saliva of Down syndrome patients. Arch Oral Biol 58:1246–1250
Megarbane A, Ravel A, Mircher C et al (2009) The 50th anniversary of the discovery of trisomy 21: the past, present, and future of research and treatment of Down syndrome. Genet Med 11:611–616
Frydman A, Nowzari H (2012) Down syndrome-associated periodontal disease: a critical review of the literature. Compend Contin Educ Dent 33:356–361
Hassold TJ, Jacobs PA (1984) Trisomy in man. Annu Rev Genet 18:69–97
Cichon P, Crawford L, Grimm WD (1998) Early-onset periodontal disease associated with Down’s syndrome—clinical interventional study. Ann Periodontol 3:370–380
Cohen MM, Winer RA, Schwartz S et al (1961) Oral aspects of mongolism. I: periodontal disease in mongolism. Oral Surg Oral Med Oral Pathol 14:92–107
Roizen NJ, Patterson D (2003) Down’s syndrome. Lancet 361:1281–1289
Sustrova M, Sarikova V (1997) Down’s syndrome—effect of increased gene expression in chromosome 21 on the function of the immune and nervous system. Bratisl Lek Listy 98:221–228
Pueschel SM (1990) Clinical aspects of Down syndrome from infancy to adulthood. Am J Med Genet Suppl 7:52–56
Smith DS (2001) Health care management of adults with Down syndrome. Am Fam Phys 64:1031–1038
Thiel R, Fowkes SW (2005) Can cognitive deterioration associated with Down syndrome be reduced? Med Hypotheses 64:524–532
Zigman WB, Lott IT (2007) Alzheimer’s disease in Down syndrome: neurobiology and risk. Ment Retard Dev Disabil Res Rev 13:237–246
Malt EA, Dahl RC, Haugsand TM et al (2013) Health and disease in adults with Down syndrome. Tidsskr Nor Laegeforen 133:290–294
Teksen F, Sayli BS, Aydin A et al (1998) Antioxidative metabolism in Down syndrome. Biol Trace Elem Res 63:123–127
Pallardo FV, Degan P, d’Ischia M et al (2006) Multiple evidence for an early age pro-oxidant state in Down syndrome patients. Biogerontology 7:211–220
Cheon MS, Shim KS, Kim SH et al (2003) Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part IV). Amino Acids 25:41–47
Midorikawa K, Kawanishi S (2001) Superoxide dismutases enhance H2O2-induced DNA damage and alter its site specificity. FEBS Lett 495:187–190
de Teunissen CE, Vente J, Steinbusch HW et al (2002) Biochemical markers related to Alzheimer’s dementia in serum and cerebrospinal fluid. Neurobiol Aging 23:485–508
Brooksbank BW, Balazs R (1984) Superoxide dismutase, glutathione peroxidase and lipoperoxidation in Down’s syndrome fetal brain. Brain Res 318:37–44
Gulesserian T, Seidl R, Hardmeier R et al (2001) Superoxide dismutase SOD1, encoded on chromosome 21, but not SOD2 is overexpressed in brains of patients with Down syndrome. J Investig Med 49:41–46
Gulesserian T, Engidawork E, Fountoulakis M et al (2001) Antioxidant proteins in fetal brain: superoxide dismutase-1 (SOD-1) protein is not overexpressed in fetal Down syndrome. J Neural Transm Suppl 61:71–84
de Haan JB, Cristiano F, Iannello RC et al (1995) Cu/Zn-superoxide dismutase and glutathione peroxidase during aging. Biochem Mol Biol Int 35:1281–1297
Muchova J, Sustrova M, Garaiova I et al (2001) Influence of age on activities of antioxidant enzymes and lipid peroxidation products in erythrocytes and neutrophils of Down syndrome patients. Free Radic Biol Med 31:499–508
Pastore A, Tozzi G, Gaeta LM et al (2003) Glutathione metabolism and antioxidant enzymes in children with Down syndrome. J Pediatr 142:583–585
Sikora E, Radziszewska E, Kmiec T et al (1993) The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging. Acta Biochim Pol 40:269–272
Moreira PI, Honda K, Zhu X et al (2006) Brain and brawn: parallels in oxidative strength. Neurology 66:S97–S101
Zhu X, Raina AK, Perry G et al (2004) Alzheimer’s disease: the two-hit hypothesis. Lancet Neurol 3:219–226
Orner G (1976) Periodontal disease among children with Down’s syndrome and their siblings. J Dent Res 55:778–782
van Reuland-Bosma W, Dijk J (1986) Periodontal disease in Down’s syndrome: a review. J Clin Periodontol 13:64–73
Seger R, Buchinger G, Stroder J (1977) On the influence of age on immunity in Down’s syndrome. Eur J Pediatr 124:77–87
Mittwoch U (1958) The leucocyte count in children with mongolism. J Ment Sci 104:457–460
Barkin RM, Weston WL, Humbert JR et al (1980) Phagocytic function in Down syndrome—I: chemotaxis. J Ment Defic Res 24(Pt 4):243–249
Khan AJ, Evans HE, Glass L et al (1975) Defective neutrophil chemotaxis in patients with Down syndrome. J Pediatr 87:87–89
Costello C, Webber A (1976) White cell function in Down’s syndrome. Clin Genet 9:603–605
Gregory L, Williams R, Thompson E (1972) Leucocyte function in Down’s syndrome and acute leukaemia. Lancet 1:1359–1361
Tan CV, Rosner F, Feldman F (1973) Nitroblue tetrazolium dye reduction in various hematologic disorders. N Y State J Med 73:952–956
Lee C, Miura K, Liu X et al (2000) Biphasic regulation of leukocyte superoxide generation by nitric oxide and peroxynitrite. J Biol Chem 275:38965–38972
Babior BM (1984) The respiratory burst of phagocytes. J Clin Invest 73:599–601
Chapple IL (1997) Reactive oxygen species and antioxidants in inflammatory diseases. J Clin Periodontol 24:287–296
Waddington RJ, Moseley R, Embery G (2000) Reactive oxygen species: a potential role in the pathogenesis of periodontal diseases. Oral Dis 6:138–151
Lee MC, Kawai Y, Shoji H et al (2004) Evidence of reactive oxygen species generation in synovial fluid from patients with temporomandibular disease by electron spin resonance spectroscopy. Redox Rep 9:331–336
Lee MC, Yoshino F, Shoji H et al (2005) Characterization by electron spin resonance spectroscopy of reactive oxygen species generated by titanium dioxide and hydrogen peroxide. J Dent Res 84:178–182
Sherman L, Dafni N, Lieman-Hurwitz J et al (1983) Nucleotide sequence and expression of human chromosome 21-encoded superoxide dismutase mRNA. Proc Natl Acad Sci U S A 80:5465–5469
Chen HI, Liou SH, Ho SF et al (2007) Oxidative DNA damage estimated by plasma 8-hydroxydeoxyguanosine (8-OHdG): influence of 4,4′-methylenebis (2-chloroaniline) exposure and smoking. J Occup Health 49:389–398
Wu LL, Chiou CC, Chang PY et al (2004) Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 339:1–9
Takane M, Sugano N, Ezawa T et al (2005) A marker of oxidative stress in saliva: association with periodontally-involved teeth of a hopeless prognosis. J Oral Sci 47:53–57
Kaufman E, Lamster IB (2002) The diagnostic applications of saliva—a review. Crit Rev Oral Biol Med 13:197–212
Hofman LF (2001) Human saliva as a diagnostic specimen. J Nutr 131:1621S–1625S
Branson BM (2004) FDA approves OraQuick for use in saliva: on March 25, the FDA approved the first rapid test for HIV in oral fluids. AIDS Clin Care 16:39
Acknowledgments
This research was supported by a Grant-in-Aid for Scientific Research (no. 18592149 to M.L., no. 19592371 to T.K. and M.L., no. 23593049 to T.K., no. 23660047 to M.L.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Komatsu, T., Lee, MCI. (2014). Oxidative Stress and Periodontal Disease in Down Syndrome. In: Ekuni, D., Battino, M., Tomofuji, T., Putnins, E. (eds) Studies on Periodontal Disease. Oxidative Stress in Applied Basic Research and Clinical Practice. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4614-9557-4_15
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9557-4_15
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4614-9556-7
Online ISBN: 978-1-4614-9557-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)